MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro-Reference-Cited by-同舟云学术

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro

Published:2010-09 Issue:3 Volume:136 Page:338-347
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Ray Swagatam,Chhabra Arvind,Chakraborty Nitya G.,Hegde Upendra,Dorsky David I.,Chodon Thinle,von Euw Erika,Comin-Anduix Begonya,Koya Richard C.,Ribas Antoni,Economou James S.,Rosenberg Steven A.,Mukherji Bijay

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. The role of CD4+ T cell responses in antitumor immunity;Pardoll;Curr. Opin. Immunol.,1998

2. CD4 T cells and their role in antitumor immune responses;Toes;J. Exp. Med.,1999

3. CD4+ T lymphocytes: a critical component of antitumor immunity;Ostrand-Rosenberg;Cancer Invest.,2005

4. A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection;Morris;Proc. Natl. Acad. Sci. U. S. A.,2005

5. Generation of T cell help through a MHC class I-restricted TCR;Kessels;J. Immunol.,2006

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ATG8 Family Proteins GABARAP and GABARAPL1 Target Antigen to Dendritic Cells to Prime CD4+ and CD8+ T Cells;Cells;2022-09-06

2. Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4+ TCR-T Cells;Frontiers in Immunology;2022-07-19

3. Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells;Cancer Cell;2021-12

4. CD29 Enriches for Cytotoxic Human CD4+ T Cells;The Journal of Immunology;2021-11-15

5. Green Synthesis of Copper Oxide Nanoparticles using Cucumis Sativus (Cucumber) Extracts and their Bio-Physical and Biochemical Characterization for Cosmetic and Dermatologic Applications;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-05-04